SEC Form 4 · accession 0001094891-17-000172
PAVmed Inc. · PAVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David S. Battleman
Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 11, 2017 · 10:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624326
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.98 | Aug 3, 2017 | A | 40,000 | A | — | Aug 2, 2027 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option shall become exercisable as to one-twelfth (1/12) of the option shares on September 30, 2017, and shall become exercisable as to one-twelfth (1/12) of the option shares on the last day of each successive fiscal quarter for the following eleven (11) fiscal quarters.